ZIM
BIIB icon

Zacks Investment Management’s Biogen BIIB Stock Holding History

Zacks Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-909
Closed -$223K – 504
2020
Q4 		$223K Sell
909
-67
-7% -$17.3K ﹤0.01% 489
2020
Q3 		$277K Sell
976
-25,410
-96% -$7.09M 0.01% 462
2020
Q2 		$7.06M Sell
26,386
-18,880
-42% -$5.68M 0.16% 124
2020
Q1 		$14.3M Buy
45,266
+217
+0.5% +$65.9K 0.35% 79
2019
Q4 		$13.4M Sell
45,049
-405
-0.9% -$112K 0.25% 92
2019
Q3 		$10.6M Buy
45,454
+61
+0.1% +$14.2K 0.21% 104
2019
Q2 		$10.6M Sell
45,393
-23
-0.1% -$5.31K 0.22% 98
2019
Q1 		$10.7M Buy
45,416
+566
+1% +$178K 0.23% 98
2018
Q4 		$13.5M Sell
44,850
-1,267
-3% -$404K 0.33% 77
2018
Q3 		$16.3M Buy
46,117
+8,310
+22% +$2.86M 0.34% 78
2018
Q2 		$11M Sell
37,807
-62
-0.2% -$17.4K 0.24% 96
2018
Q1 		$10.4M Buy
37,869
+232
+0.6% +$72K 0.23% 98
2017
Q4 		$12M Sell
37,637
-137
-0.4% -$44K 0.26% 90
2017
Q3 		$11.8M Buy
37,774
+16,193
+75% +$4.79M 0.28% 93
2017
Q2 		$5.86M Sell
21,581
-101
-0.5% -$26.7K 0.15% 131
2017
Q1 		$5.93M Buy
+21,682
New +$6.13M 0.15% 127
2015
Q3 		– Sell
-1,124
Closed -$454K – 589
2015
Q2 		$454K Buy
+1,124
New +$451K 0.01% 453
2015
Q1 		– Sell
-1,479
Closed -$502K – 628
2014
Q4 		$502K Buy
+1,479
New +$478K 0.02% 410
2014
Q2 		– Sell
-1,390
Closed -$425K – 659
2014
Q1 		$425K Buy
+1,390
New +$441K 0.02% 465
2013
Q4 		– Sell
-6,007
Closed -$1.45M – 669
2013
Q3 		$1.45M Sell
6,007
-11
-0.2% -$2.46K 0.06% 191
2013
Q2 		$1.29M Buy
+6,018
New +$1.29M 0.06% 193

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zacks Investment Management's BIIB Position: Q1 2021 in Review

Zacks Investment Management sold out of Biogen (BIIB) in Q1 2021, closing a stake of 909 shares — an estimated $223K sold.

Zacks Investment Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $16.3M in Q3 2018. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Zacks Investment Management reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Zacks Investment Management sold 909 Biogen shares in Q1 2021, an estimated $223K.
  • Zacks Investment Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
  • Zacks Investment Management's Biogen position peaked at $16.3M in Q3 2018.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Zacks Investment Management's 13F filing for Q1 2021, filed 17 May 2021.